Penile Cancer Clinical Trials

ReadTheTrial indexes 2 studies for Penile Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Penile Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials for Penile Cancer

Neoadjuvant Therapy With EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) for Penile Squamous Cell Carcinoma With Penile Preservation Difficulty or Regional Lymph Node Metastasis: A Single-Arm, Phase II Clinical Trial

NCT07518979 · NOT YET RECRUITING · Phase 2

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma: A Prospective, Single-Arm, Phase I Clinical Trial

NCT07054307 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Penile Cancer?

There are 2 clinical trials listed for Penile Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Penile Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Penile Cancer trials in?

Current Penile Cancer trials are distributed across: Phase 2 (1), Phase 1 (1).

Find More Trials